![Taro Pharmaceutical Industries Ltd. Logo](/news-release/logo/214827/0/214827.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A32&size=2)
Taro and Alkem to Collaborate on Product Development For U.S. and Other Markets
December 29, 2005 07:00 ET
|
Taro Pharmaceutical Industries Ltd.
HAWTHORNE, N.Y., Dec. 29, 2005 (PRIMEZONE) -- Taro Pharmaceutical Industries Ltd. (Nasdaq:TARO) (the "Company") reported today that it has entered into an agreement with Alkem Laboratories Ltd....
![Taro Pharmaceutical Industries Ltd. Logo](/news-release/logo/214827/0/214827.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A32&size=2)
Taro Receives Approval For Mupirocin Ointment USP, 2% ANDA
September 23, 2005 12:50 ET
|
Taro Pharmaceutical Industries Ltd.
HAWTHORNE, N.Y., Sept. 23, 2005 (PRIMEZONE) -- Taro Pharmaceutical Industries Ltd. (Nasdaq:TARO) reported today that Taro Pharmaceuticals U.S.A., Inc. has received approval from the U.S. Food and...
![Taro Pharmaceutical Industries Ltd. Logo](/news-release/logo/214827/0/214827.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A32&size=2)
Taro Receives Approval for Halobetasol Propionate Cream, 0.05% ANDA
August 05, 2005 07:00 ET
|
Taro Pharmaceutical Industries Ltd.
HAWTHORNE, N.Y., Aug. 5, 2005 (PRIMEZONE) -- Taro Pharmaceutical Industries Ltd. (Nasdaq:TARO) reported today that Taro Pharmaceuticals U.S.A., Inc. has received approval from the U.S. Food and Drug...
![Taro Pharmaceutical Industries Ltd. Logo](/news-release/logo/214827/0/214827.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A32&size=2)
Taro to Report First Quarter 2005 Results and Conduct Conference Call on April 26, 2005
April 20, 2005 16:04 ET
|
Taro Pharmaceutical Industries Ltd.
HAWTHORNE, N.Y., April 20, 2005 (PRIMEZONE) -- Taro Pharmaceutical Industries Ltd. (NASDAQ:TARO) intends to report financial results for the first quarter of 2005 prior to the NASDAQ market opening...
![Taro Pharmaceutical Industries Ltd. Logo](/news-release/logo/214827/0/214827.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A32&size=2)
Taro to Report 4th Quarter and Full Year 2004 Results and Conduct Conference Call on February 24, 2005
February 22, 2005 12:58 ET
|
Taro Pharmaceutical Industries Ltd.
HAWTHORNE, N.Y., Feb. 22, 2005 (PRIMEZONE) -- Taro Pharmaceutical Industries Ltd. (Nasdaq:TARO) intends to report financial results for the fourth quarter and full year 2004 prior to the Nasdaq...
![Taro Pharmaceutical Industries Ltd. Logo](/news-release/logo/214827/0/214827.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A32&size=2)
Taro Receives Approval for Hydrocortisone Butyrate Ointment, 0.1% ANDA
December 27, 2004 17:03 ET
|
Taro Pharmaceutical Industries Ltd.
HAWTHORNE, N.Y., Dec. 27, 2004 (PRIMEZONE) -- Taro Pharmaceutical Industries Ltd. (Nasdaq:TARO) reported today that it has received approval from the U.S. Food and Drug Administration for its...
![Taro Pharmaceutical Industries Ltd. Logo](/news-release/logo/214827/0/214827.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A32&size=2)
Taro USA Receives Approval for Halobetasol Propionate Ointment, 0.05% ANDA
December 16, 2004 14:50 ET
|
Taro Pharmaceutical Industries Ltd.
HAWTHORNE, N.Y., Dec. 16, 2004 (PRIMEZONE) -- Taro Pharmaceutical Industries Ltd. (Nasdaq:TARO) reported today that Taro Pharmaceuticals U.S.A., Inc. ("Taro USA"), its U.S. affiliate, has received...
![Taro Pharmaceutical Industries Ltd. Logo](/news-release/logo/214827/0/214827.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A32&size=2)
Taro USA Receives Approval For Mometasone Furoate Ointment, USP 0.1% ANDA
December 06, 2004 07:00 ET
|
Taro Pharmaceutical Industries Ltd.
HAWTHORNE, N.Y., Dec. 6, 2004 (PRIMEZONE) -- Taro Pharmaceutical Industries Ltd. (Nasdaq:TARO) reported today that Taro Pharmaceuticals U.S.A., Inc. ("Taro USA"), its U.S. affiliate, has received...
![Taro Pharmaceutical Industries Ltd. Logo](/news-release/logo/214827/0/214827.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A32&size=2)
Taro USA Receives Approval For Mometasone Furoate Ointment, USP 0.1% ANDA
December 03, 2004 20:07 ET
|
Taro Pharmaceutical Industries Ltd.
HAWTHORNE, N.Y., Dec. 3, 2004 (PRIMEZONE) -- Taro Pharmaceutical Industries Ltd. (Nasdaq:TARO) reported today that Taro Pharmaceuticals U.S.A., Inc. ("Taro USA"), its U.S. affiliate, has received...
![Taro Pharmaceutical Industries Ltd. Logo](/news-release/logo/214827/0/214827.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A32&size=2)
Taro Reports `A+' Bond Rating In Israel
November 22, 2004 07:00 ET
|
Taro Pharmaceutical Industries Ltd.
HAWTHORNE, N.Y., Nov. 22, 2004 (PRIMEZONE) -- Taro Pharmaceutical Industries Ltd. ("Taro," "the Company," (Nasdaq:TARO)) today reported that it has received an "A+" rating from Maalot, the Israeli...